Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and…

Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive Control of Atherosclerotic Cardiovascular Disease Risk in Patients with Homozygous Familial Hypercholesterolemia
Hiroshi Yoshida
Journal of Atherosclerosis and Thrombosis11 Sep 2026Peer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaJ-STAGE
Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study
Tianshu Gu, Yang Chen, Nan Zhang +5
British Journal of Clinical Pharmacology7 Jul 2026Peer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
Sex differences in psychosocial burden and healthcare access among U.S. adults with premature atherosclerotic cardiovascular disease
Niti Dalal, Katherine Mills, Yilin Yoshida +3
American journal of preventive cardiology17 Jul 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Cardiometabolic risk factors and Mediterranean diet adherence in patients with premature atherosclerotic cardiovascular disease in Iran
Alireza Taghavi, Ehsan Shahrestanaki, Alireza Dehghannayeri +3
Journal of Diabetes and Metabolic Disorders29 Oct 2026Peer-reviewedLicence not statedFull textEpidemiology & public healthPMC
Plasma p-tau181 moderates the association between ten-year atherosclerotic cardiovascular disease risk and mild cognitive impairment – HABS-HD
Joey A. Contreras, Nancy E. Ortega, Raymond Jones +2
Frontiers in aging neuroscience16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{kongmalai2026economic,
  title = {{Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease}},
  author = {Tanawan Kongmalai and Natthakan Chitpim and Varalak Srinonprasert and Hathaichanok Sumalee and Pattara Leelahavarong},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-73139-w},
  url = {https://www.nature.com/articles/s41598-026-73139-w},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
AU  - Tanawan Kongmalai
AU  - Natthakan Chitpim
AU  - Varalak Srinonprasert
AU  - Hathaichanok Sumalee
AU  - Pattara Leelahavarong
PY  - 2026
DA  - 2026/10/06
JO  - Scientific Reports
DO  - 10.1038/s41598-026-73139-w
UR  - https://www.nature.com/articles/s41598-026-73139-w
SN  - 2045-2322
ER  -

Related

Cite